Buried deep within the DoD FY23 budget request by weapon system, the US Army has officially chosen the contractor(s) for the Next Generation Squad Weapons (NGSW) program.
NGSW is a prototyping effort by the Army that consists of a new rifle (NGSW-R) and automatic rifle (NGSW-AR), chambered in a new high tech 6.8mm cartridge, set to replace the aging M16, M4A1 Carbines and the M249 Squad Automatic Weapon, chambered in a 5.56 NATO round.
The NGSW has been in competitive prototyping testing with three defense firms, including SIG Sauer, General Dynamics – OTS, and Textron Systems.
On page 53/106 of the budget request, the Army expects to procure 29,046 NGSWs in 2023.
“Starts funding for the procurement and fielding of 1,704 NGSW-AR, which is the planned replacement for the M249 Squad Automatic Weapon (SAW) within the Close Combat Force; Procurement and fielding of 15,348 NGSW-R which is the planned replacement for the M4A1 Carbine within the Close Combat Force; and procurement and fielding of 11,994 Next Generation Squad Weapons Fire Controls,” the document read.
The document didn’t mention the prime contractor(s), though that should be announced later this year.
The Army will be fielding these new main battle rifles and machine guns next year — just as tensions with Russia heat up.
by Tyler Durden
Join: 👉 https://t.me/acnewspatriots
The opinions expressed by contributors and/or content partners are their own and do not necessarily reflect the views of AC.NEWS
Disclaimer: This article may contain statements that reflect the opinion of the author. The contents of this article are of sole responsibility of the author(s). AC.News will not be responsible for any inaccurate or incorrect statement in this article www.ac.news websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner. Reprinting this article: Non-commercial use OK. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.
Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.
Discussion about this post